Cotton Rat: Animal Model Predictive of Clinical Responses to HSV Vaccines
棉鼠:预测 HSV 疫苗临床反应的动物模型
基本信息
- 批准号:8094269
- 负责人:
- 金额:$ 27.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcyclovirAddressAnimal ModelAnimalsBindingCaviaCell surfaceChildClinicalClinical TrialsCotton RatsCouplesDiseaseEpidemiologic StudiesEpidemiologyFemaleFutureGenderGlycoproteinsGoalsHIVHealthHeparitin SulfateHerpes Simplex Virus VaccinesHerpesvirus 1HormonalHumanHuman Herpesvirus 2Immune responseIn VitroIncidenceInfectionLocal MicrobicidesModelingMorbidity - disease rateMothersMusNational Institute of Allergy and Infectious DiseaseOralOutcomePRO 2000PhasePrevalencePreventionPrevention strategyPublic HealthReagentRecurrenceResearchRiskSexually Transmitted DiseasesSimplexvirusSkinSmall Business Technology Transfer ResearchSubunit VaccinesTestingTherapeutic InterventionVaccinesVaginaViralVirusWomanaluminum sulfatecomparative efficacygenital herpeshigh riskhuman diseaseinsightmalemenmicrobicidemonophosphoryl lipid Anovelnovel vaccinespreclinical evaluationpreclinical studypredictive modelingpreventresponsesulfated polymertopical antiviraltransmission processvaccine developmentvaccine efficacy
项目摘要
DESCRIPTION (provided by applicant): Genital herpes is one of the most prevalent sexually transmitted infections worldwide and is associated with substantial morbidity. The impact of genital herpes as a public health threat is amplified because of its epidemiologic synergy with HIV. Epidemiological studies consistently demonstrate that HSV infection increases the risk of HIV transmission and acquisition. The increasing prevalence of primary HSV infection, clinical recurrences and high rates of silent reactivation fuel the spread of both HSV and HIV and highlight the urgent need for novel prevention strategies. HSV vaccine development has been elusive, however, the most promising results were obtained in two trials with a HSV-2 glycoprotein D (gD) subunit vaccine developed by GlaxoSmithKline (GSK) in which the vaccine provided partial protection for women who were seronegative for both HSV-1 and HSV-2 at baseline, but failed to protect men or to protect HSV-1 seropositive women. To address the limitations and inadequacies of the current models, we established female (vaginal) and male (disrupted penile skin) cotton rat models of genital herpes. We have also established models of oral and ocular HSV- 1 infection, thus providing the opportunity to compare vaccine responses in HSV-1 seropositive and HSV-1 naive animals. Additional advantages of the cotton rat include the availability of reagents to study humoral and cellular mucosal and systemic immune responses. The overall goal of this Phase I STTR is to determine if the cotton rat provides a model predictive of clinical responses to vaccines by comparing the efficacy of the GSK gD subunit vaccine in male and female cotton rats. We hypothesize that the vaccine will provide greater protection in HSV-naive females compared to males and in HSV-1 naove compared to HSV-1 seropositive females, thus recapitulating what happened in the human clinical trials. We will compare the impact of the vaccine on primary infection and disease, rates of clinical and subclinical recurrences, and mucosal and systemic humoral and cellular immune responses. Results obtained will provide insights into the mechanisms underlying gender specific responses and establish the framework for future studies to evaluate next generation vaccines as well as other prevention strategies.
PUBLIC HEALTH RELEVANCE: Genital herpes is one of the most prevalent sexually transmitted infections worldwide and is associated with substantial morbidity. Epidemiological studies consistently demonstrate that HSV infection increases the risk of HIV transmission and acquisition. HSV vaccine development has been elusive, however, the most promising results were obtained in two trials with a glycoprotein D (gD) subunit vaccine developed by GlaxoSmithKline (GSK) in which the vaccine provided partial protection for women who were seronegative for both HSV-1 and HSV-2 at baseline, but failed to protect men or to protect HSV-1 seropositive women. To address the limitations and inadequacies of the current models, we established female (vaginal) and male (disrupted penile skin) cotton rat models of genital herpes. The goal of Phase 1 of this STTR application is to compare the efficacy of the GSK gD-2-Alum monophosphoryl lipid A (MPL) vaccine in female and male cotton rats.
描述(由申请人提供):生殖器疱疹是全球最流行的性传播感染之一,并与大量发病率相关。生殖器疱疹作为一种公共卫生威胁的影响被放大,因为它与艾滋病毒的流行病学协同作用。流行病学研究一致表明,HSV感染增加了HIV传播和获得的风险。原发性HSV感染、临床复发和高沉默再激活率的日益增加的患病率助长了HSV和HIV的传播,并突出了对新的预防策略的迫切需要。HSV疫苗的开发一直是难以捉摸的,然而,最有希望的结果是在两项试验中获得的HSV-2糖蛋白D(gD)亚单位疫苗开发的葛兰素史克(GSK),其中疫苗提供了部分保护的妇女谁是血清阴性的HSV-1和HSV-2在基线,但未能保护男性或保护HSV-1血清阳性的妇女。为了解决现有模型的局限性和不足,我们建立了生殖器疱疹的雌性(阴道)和雄性(阴茎皮肤破裂)棉鼠模型。我们还建立了口腔和眼部HSV- 1感染模型,从而提供了比较HSV-1血清阳性和HSV-1未感染动物的疫苗应答的机会。棉鼠的其他优势包括可获得研究体液和细胞粘膜和全身免疫反应的试剂。本I期STTR的总体目标是通过比较GSK gD亚单位疫苗在雄性和雌性棉鼠中的有效性,确定棉鼠是否可提供预测疫苗临床应答的模型。我们假设疫苗将在HSV-初治女性中提供比男性更大的保护,并且在HSV-1初治女性中提供比HSV-1血清阳性女性更大的保护,从而概括了人类临床试验中发生的情况。我们将比较疫苗对原发感染和疾病的影响,临床和亚临床复发率,粘膜和全身体液和细胞免疫应答。获得的结果将提供深入了解性别特异性反应的机制,并为未来的研究建立框架,以评估下一代疫苗以及其他预防策略。
公共卫生关系:生殖器疱疹是世界上最普遍的性传播感染之一,并与大量的发病率。流行病学研究一致表明,HSV感染增加了HIV传播和获得的风险。HSV疫苗的开发一直难以捉摸,然而,最有希望的结果是在两项试验中获得的糖蛋白D(gD)亚单位疫苗开发的葛兰素史克(GSK),其中疫苗提供了部分保护的妇女谁是血清阴性的HSV-1和HSV-2在基线,但未能保护男性或保护HSV-1血清阳性的妇女。为了解决现有模型的局限性和不足,我们建立了生殖器疱疹的雌性(阴道)和雄性(阴茎皮肤破裂)棉鼠模型。本STTR申请的I期研究旨在比较GSK gD-2-明矾单磷酰脂质A(MPL)疫苗在雌性和雄性棉鼠中的有效性。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marina S Boukhvalova其他文献
Marina S Boukhvalova的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marina S Boukhvalova', 18)}}的其他基金
The Cotton Rat: Translational Model of Influenza Vaccines for the Elderly
棉花鼠:老年人流感疫苗的转化模型
- 批准号:
8396467 - 财政年份:2012
- 资助金额:
$ 27.5万 - 项目类别:
The Cotton Rat: Translational Model of Influenza Vaccines for the Elderly
棉花鼠:老年人流感疫苗的转化模型
- 批准号:
8516959 - 财政年份:2012
- 资助金额:
$ 27.5万 - 项目类别:
Cotton Rat: Animal Model Predictive of Clinical Responses to HSV Vaccines
棉鼠:预测 HSV 疫苗临床反应的动物模型
- 批准号:
8000121 - 财政年份:2010
- 资助金额:
$ 27.5万 - 项目类别:
Effect of immunosenescence on innate immune responses to RSV
免疫衰老对 RSV 先天免疫反应的影响
- 批准号:
8194503 - 财政年份:2010
- 资助金额:
$ 27.5万 - 项目类别:
Cotton Rat: Animal Model Predictive of Clinical Responses to HSV Vaccines
棉鼠:预测 HSV 疫苗临床反应的动物模型
- 批准号:
8194517 - 财政年份:2010
- 资助金额:
$ 27.5万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 27.5万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 27.5万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 27.5万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 27.5万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 27.5万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 27.5万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 27.5万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 27.5万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 27.5万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 27.5万 - 项目类别:
Research Grant